EMERGENT BIOSOLUTIONS INC. Variable Interest Entity, Measure of Activity, Expense
EMERGENT BIOSOLUTIONS INC. (EBS) reported Variable Interest Entity, Measure of Activity, Expense of -$348.00 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense · last filed 2013-11-08
- EMERGENT BIOSOLUTIONS INC. variable interest entity, measure of activity, expense for the quarter ending 2013-09-30 was -$1.00K.
- EMERGENT BIOSOLUTIONS INC. variable interest entity, measure of activity, expense for the quarter ending 2013-06-30 was -$537.00K.
- EMERGENT BIOSOLUTIONS INC. variable interest entity, measure of activity, expense for the quarter ending 2013-03-31 was $190.00K.
- EMERGENT BIOSOLUTIONS INC. variable interest entity, measure of activity, expense for the quarter ending 2012-09-30 was -$469.00K.
| Period end | Variable Interest Entity, Measure of Activity, Expense 3 month | Variable Interest Entity, Measure of Activity, Expense 6 month | Variable Interest Entity, Measure of Activity, Expense 9 month |
|---|---|---|---|
| 2013-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$538.00K derived: sum of 2 quarters · filed 2013-11-08 | -$348.00K 10-Q · filed 2013-11-08 |
| 2013-06-30 | -$537.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$347.00K 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $190.00K 10-Q · filed 2013-05-03 | ||
| 2012-09-30 | -$469.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $3.16M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $3.63M 10-Q · filed 2012-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |